Oral oncolytics (oral cancer treatments) are increasingly prevalent as potentially more convenient, self-administered approaches to treatment. However, many healthcare organizations have not yet established a formal program for managing treatment with oral oncolytics. Challenges around care coordination and support, adverse effects, inadequate patient education, and financial toxicity can lead to some patients unnecessarily modifying or discontinuing oral oncolytics treatment.

Standardizing a therapy management plan as a health system is the foundational first step to ensuring consistency in workflow and addressing challenges to patient adherence and persistence. With this foundation in place, the insights highlighted below can be adapted, combined, and integrated to build a comprehensive approach based on your health system’s needs and capacity. Read on for five strategies to consider implementing to appropriately improve adherence and persistence to oral oncolytics treatment at all stages of the patient journey.